• Amygdala Neurosciences, NIAAA to Conduct ANS-6637 Study americanpharmaceuticalreview
    September 13, 2018
    Amygdala Neurosciences announced the National Institute on Alcohol Abuse and Alcoholism (NIAAA, a division of NIH) will fund and conduct a Phase 2, human laboratory study of ANS-6637 for the treatment of alcohol use disorder.
PharmaSources Customer Service